This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Jan;61(1):6-8.

doi: 10.1053/j.ajkd.2012.10.004.

Erythropoiesis-stimulating agents on trial: are higher dosages causing harm?

C Michael Chaknos, Jeffrey S Berns

PMID: 23245737
DOI: 10.1053/j.ajkd.2012.10.004

Editorial

Erythropoiesis-stimulating agents on trial: are higher dosages causing harm?

C Michael Chaknos et al. Am J Kidney Dis. 2013 Jan.

. 2013 Jan;61(1):6-8.

doi: 10.1053/j.ajkd.2012.10.004.

Authors

C Michael Chaknos, Jeffrey S Berns

PMID: 23245737
DOI: 10.1053/j.ajkd.2012.10.004

No abstract available

PubMed Disclaimer

Comment on

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.
Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Koulouridis I, et al. Am J Kidney Dis. 2013 Jan;61(1):44-56. doi: 10.1053/j.ajkd.2012.07.014. Epub 2012 Aug 22. Am J Kidney Dis. 2013. PMID: 22921639 Free PMC article.

Similar articles

Erythropoiesis-Stimulating Agents and Cancer: Myth or Truth.
Choi MJ, Yee J. Choi MJ, et al. Adv Chronic Kidney Dis. 2019 Jul;26(4):221-224. doi: 10.1053/j.ackd.2019.04.001. Adv Chronic Kidney Dis. 2019. PMID: 31477251 No abstract available.
Erythropoiesis-stimulating agents--time for a reevaluation.
Unger EF, Thompson AM, Blank MJ, Temple R. Unger EF, et al. N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6. N Engl J Med. 2010. PMID: 20054037 No abstract available.
[Use of erythropoiesis stimulating agents].
Abreu PF, Romão Junior JE, Bastos MG. Abreu PF, et al. J Bras Nefrol. 2014 Mar;36(1 Suppl 1):19-23. doi: 10.5935/0101-2800.2014s006. J Bras Nefrol. 2014. PMID: 24770599 Portuguese. No abstract available.
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.
Hazzan AD, Shah HH, Hong S, Sakhiya V, Wanchoo R, Fishbane S. Hazzan AD, et al. Kidney Int. 2014 Jul;86(1):34-9. doi: 10.1038/ki.2013.528. Epub 2014 Jan 8. Kidney Int. 2014. PMID: 24402094 Review.
Anemia of chronic kidney disease: Treat it, but not too aggressively.
Nakhoul G, Simon JF. Nakhoul G, et al. Cleve Clin J Med. 2016 Aug;83(8):613-24. doi: 10.3949/ccjm.83a.15065. Cleve Clin J Med. 2016. PMID: 27505883 Review.

See all similar articles

Cited by

Effects of Individualized Anemia Therapy on Hemoglobin Stability: A Randomized Controlled Pilot Trial in Patients on Hemodialysis.
Fuertinger DH, Wang LC, Jörg DJ, Rivera Fuentes L, Ye X, Casper S, Zhang H, Mermelstein A, Cherif A, Ho K, Raimann JG, Tisdale L, Kotanko P, Thijssen S. Fuertinger DH, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1138-1147. doi: 10.2215/CJN.0000000000000488. Epub 2024 Jun 11. Clin J Am Soc Nephrol. 2024. PMID: 38861324
Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents.
Brenner N, Kommalapati A, Ahsan M, Ganguli A. Brenner N, et al. J Nephrol. 2020 Apr;33(2):267-275. doi: 10.1007/s40620-019-00680-5. Epub 2019 Nov 28. J Nephrol. 2020. PMID: 31782127 Review.
Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.
Warady BA, Silverstein DM. Warady BA, et al. Pediatr Nephrol. 2014 Sep;29(9):1493-505. doi: 10.1007/s00467-013-2557-x. Epub 2013 Sep 5. Pediatr Nephrol. 2014. PMID: 24005791 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information